Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis via Paracrine Action

Background SENP1 (Sentrin-specific protease 1) is involved in heart disease by regulating intracellular SUMOylation. However, the role of cell type-specific SENP1 in the setting of myocardial infarction (MI) remains to be defined. We determined whether cardiomyocyte-specific SENP1 regulates maladaptive remodeling in the ischemic heart. Methods We generated cardiomyocyte-specific SENP1 knockout and overexpression mice to assess cardiac function and ventricular remodeling responses under physiological and pathological conditions. Adult mouse cardiomyocytes and fibroblasts were separated to observe the paracrine effects of cardiomyocytes. DIA proteomic assay and bioinformatic analysis were performed to detect differential proteins in primary cardiomyocytes. Single-cell sequencing data were analyzed to identify key cardiomyocyte cluster regulated by SENP1 after MI. Mass spectrometry was performed to search for key effector proteins regulated by SENP1. Results SENP1 expression reduced in post-infarction mice and patients with heart failure. Cardiomyocyte-specific SENP1 deficiency (genetic or adeno-associated virus (AAV)-mediated) triggered a myocardial fibrotic response and progressive cardiac dysfunction. MI exacerbated the poor ventricular remodeling response mediated by SENP1 deletion, SENP1 overexpression improved cardiac function and reduced fibrosis. Further, we found that increased cardiac fibrosis in the cardiomyocyte-specific SENP1 deletion mice, associated with increased Fn expression and secretion in cardiomyocytes, promoted fibroblast activation in response to myocardial injury. Mechanistically, SENP promoted deSUMOylation of the HSP90ab1 (heat shock protein 90 alpha, class B, member 1) Lys72 and ubiquitin-dependent degradation, which reduced HSP90ab1-mediated phosphorylation of STAT3 (signal transducer and activator of transcription 3) and transcriptional activation of Fn, and then reduced fibroblast activation in the indirect coculture model. On the other hand, AAV-mediated mutation of the HSP90ab1 Lys72 ameliorated adverse ventricular remodeling and dysfunction post-MI. Conclusions SENP1 is essential for repressing STAT3-mediated Fn transcription by regulating deSUMOylation of HSP90ab1. Blockade of HSP90ab1 SUMOylation at the Lys72 site is a novel therapy effective in reversing adverse ventricular remodeling post-MI.

[1]  K. Tanonaka,et al.  Involvement of Hsp90 in NLRP3 inflammasome activation in the failing heart following myocardial infarction in rats. , 2023, Biochemical pharmacology.

[2]  J. Bargehr,et al.  Epicardially secreted fibronectin drives cardiomyocyte maturation in 3D-engineered heart tissues , 2023, Stem cell reports.

[3]  Guanwei Fan,et al.  SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity , 2022, Journal of pharmaceutical analysis.

[4]  Fang-Yuan Liu,et al.  SENP1 Protects Against Pressure Overload‐Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling , 2022, Journal of the American Heart Association.

[5]  Sheng Wang,et al.  Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma , 2022, Oncogene.

[6]  A. Vertegaal Signalling mechanisms and cellular functions of SUMO , 2022, Nature Reviews Molecular Cell Biology.

[7]  Chenying Fu,et al.  Signaling pathways and targeted therapy for myocardial infarction , 2022, Signal Transduction and Targeted Therapy.

[8]  Jian Hu,et al.  DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics , 2022, Circulation.

[9]  Hyun-Ju Park,et al.  A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects , 2022, Theranostics.

[10]  A. Orekhov,et al.  Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing , 2022, International journal of molecular sciences.

[11]  Juan Li,et al.  Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy , 2021, Redox biology.

[12]  Hongshan Chen,et al.  Inhibition of HSP90 S‐nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway , 2021, British journal of pharmacology.

[13]  Xiangxuan Zhao,et al.  The HSP90 inhibitor, XL888, enhanced cell apoptosis via downregulating STAT3 after insufficient radiofrequency ablation in hepatocellular carcinoma. , 2021, Life sciences.

[14]  P. Nisticò,et al.  Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology , 2021, Journal of experimental & clinical cancer research : CR.

[15]  K. Tanonaka,et al.  Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice. , 2021, European journal of pharmacology.

[16]  M. Giacca,et al.  Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner , 2021, Nature Communications.

[17]  Dan Liu,et al.  Rictor/mTORC2 involves mitochondrial function in ES cells derived cardiomyocytes via mitochondrial Connexin 43 , 2020, Acta Pharmacologica Sinica.

[18]  E. Yeh,et al.  SUMO: From Bench to Bedside. , 2020, Physiological reviews.

[19]  Tian-Le Xu,et al.  DUSP6 SUMOylation protects cells from oxidative damage via direct regulation of Drp1 dephosphorylation , 2020, Science Advances.

[20]  Xiang Hu,et al.  Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3 , 2020, Circulation research.

[21]  M. Donohoe,et al.  Yy1 regulates Senp1 contributing to AMPA receptor GluR1 expression following neuronal depolarization , 2019, Journal of Biomedical Science.

[22]  Gang Huang,et al.  Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening , 2019, Basic Research in Cardiology.

[23]  Y. Liao,et al.  HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis , 2019, Hypertension.

[24]  J. Molkentin,et al.  Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure , 2018, Circulation.

[25]  Yuqiang Ding,et al.  TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain , 2018, Nature Communications.

[26]  L. Kenner,et al.  HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. , 2017, Cellular signalling.

[27]  M. Chawla-Sarkar,et al.  Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy , 2016, Molecular and Cellular Biology.

[28]  D. Agard,et al.  Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase , 2016, Science.

[29]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[30]  E. Yeh,et al.  SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer , 2016, Oncogene.

[31]  U. Sohn,et al.  SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8⁺ T cells in mice. , 2015, Cellular signalling.

[32]  K. Chan,et al.  Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-β1 and collagen synthesis. , 2015, Journal of autoimmunity.

[33]  M. Pfreundschuh,et al.  Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor. , 2015, The Journal of clinical investigation.

[34]  S. Xue,et al.  SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway. , 2014, Cardiovascular research.

[35]  T. Sasada,et al.  Human dermal fibroblast migration induced by fibronectin in autocrine and paracrine manners , 2014, Experimental dermatology.

[36]  Mark A Sussman,et al.  Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth , 2013, Basic Research in Cardiology.

[37]  L. Luo,et al.  Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3 , 2012, PloS one.

[38]  Wolfgang Rottbauer,et al.  Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization. , 2012, Genes & development.

[39]  J. Buchner,et al.  Asymmetric activation of the hsp90 dimer by its cochaperone aha1. , 2010, Molecular cell.

[40]  D. Rockey,et al.  Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src/ERK-regulated signaling pathway. , 2009, Gastroenterology.

[41]  M. Raftery,et al.  NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture , 2008, Acta Neuropathologica.

[42]  N. D. Clarke,et al.  Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.

[43]  M. Dasso,et al.  Modification in reverse: the SUMO proteases. , 2007, Trends in biochemical sciences.

[44]  L. Pearl,et al.  Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex , 2006, Nature.

[45]  G. Rogler,et al.  Autocrine Fibronectin-Induced Migration of Human Colonic Fibroblasts , 2004, American Journal of Gastroenterology.